BY INDUSTRY
Sponsors
Your mission to drive innovation and bring life-changing treatments to patients aligns with IMC’s commitment to revolutionize adherence-focused technologies.
Solutions
Manage Adherence
Adherence to a prescribed regimen is crucial for ensuring optimal participant outcomes. Med-ic®, eCap™, and CertiScan® work together to track medication consumption and automatically help participants stay on track. CertiScan® can identify aberrant dosing patterns, enabling you to intervene proactively and remotely. We help you support participants in adhering to their treatment plans.
Make Data-Driven Decisions
Med-ic®
and eCap™ automatically record each dose time without burdening participants. CertiScan® stores and centralizes adherence data, providing you with analytics, reports, and insights on-demand, enabling you to monitor trial progress, identify trends, and make proactive decisions.st
Safeguard Trials
The CertiScan® Adherence Platform can be a critical element in an FDA-mandated risk estimation and mitigation strategy (REMS). With automatic interventions such as mobile smart reminders and targeted educational messages, you can keep participants engaged and adherence levels high. You can also use CertiScan® to detect drug misuse, diversion, tampering, and take remote intervention actions.
Reach Endpoints Sooner
IMC’s solutions streamline data collection, analysis, and intervention, allowing you to reach your endpoints faster and reduce documentation. Analysis of adherence data can help you detect an efficacy signal earlier than otherwise, avoiding unnecessary continuation. The ROI of these measures can be tremendous.
Learn More about the Products
that Power our Solutions
Consumer-quality software for clinical trials. Securely store, analyze, and action the data from smart packaging and other adherence devices. The CertiScan® Adherence Platform
includes web portals, mobile apps, developer tools, and a secure, central cloud.
ROI
Our experts have modelled the relationship between statistical power, sample size and medication adherence.
Their findings? For every 1% adherence increase, there can be a 2% reduction in trial size (N) while holding statistical power constant.
Considering that many trials currently only reach 50% adherence, there’s lots of room for improvement – and tremendous ROI.
Direct Savings from Reduced N
Processing a participant is expensive. Requiring a smaller sample size could amount to millions of dollars in savings.
Additional Weeks of Patent Protection
Smaller N means a faster trial, potentially by months. This could amount to tens of millions of dollars in additional revenue.
Compensate for Low or Slow Enrollments
It can be challenging to recruit enough participants - especially for niche diseases and even worldwide. Better data means fewer patients are needed overal.
Use Cases
Accurate data for transformative solutions.
Smart packaging is the ideal data source: it is accurate, automatic, and passive. There is no extra effort on the participant’s part since they were going to take a dose anyways (or not - which smart packaging can also detect!)
This data feeds into the CertiScan® Adherence Platform and other software systems to power numerous solutions.
Inappropriate medication use is widespread in clinical research. This can harm individual participant outcomes, jeopardize trial outcomes, and cause hidden errors that are only discovered post market or after publishing (such as a poorly titrated dosage or undiscovered side effect).
Our solutions make it easy to detect and treat these harmful issues. Many protective features are automatic, such as mobile reminders, misuse alerts, targeted coaching.Detect and Treat:
- Medication non-adherence
- Medication misuse or abuse
- Temperature exposure and spoilage
- Expiry
- Tampering, fraud, and other lot or batch issues
Shorter trials that reach their endpoints more quickly can gain weeks or months of additional patent protection. This can amount to substantial additional revenue.
Our solutions help studies reach last dose, last participant sooner.Improve timelines by:
- Automating data collection
- Replacing diaries and ePRO with smart packaging
- Letting CertiScan preprocess and analyze data
- Integrating CertiScan with RTSMs, EDCs, and other platforms
- Conducting adaptive trials
Clinical trials are becoming increasingly complex and expensive. Certain activities in a protocol seem straightforward on paper, but in practice can translate into dozens of hours of site work.
Use our solutions to help eliminate needless overhead and streamline processes.Achieve efficiencies and reduce costs by:
- Automating data collection
- Basing site inventories on consumption rates
- Conducting adaptive trials
- Conducting decentralized trials
New, technology-first strategies are transforming clinical trials. DCTs, participant diversity initiatives, and AI tools are changing from “nice-to-haves” into “must-haves”.
Our solutions are modern tools for modern trials that can help researchers and other stakeholders gain and maintain an advantage.Adopt CertiScan and smart packaging to:
- Meet FDA trial modernization guidelines
- Model PK and PD with adherence data
- Satisfy internal and external innovation requirements
- Build accurate, objective datasets for use in AI models, participant diversity initiatives, DCT tools, and more
- Publish unique studies that stand out in the literature
